Skip to main content
. Author manuscript; available in PMC: 2022 May 12.
Published in final edited form as: Pharm Res. 2021 May 12;38(5):803–817. doi: 10.1007/s11095-021-03046-4

Fig. 8: NL-1 protects neuronal cells against oxygen glucose deprivation and reperfusion (OGDR).

Fig. 8:

N2a cells were exposed to OGDR conditions for 3 hours and reperfused for 24 hours. The fluorescence intensity from Amplex Red assay is plotted as a percentage on control cells for a series of NL-1 concentrations versus vehicle control (*p<0.05).